Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Ariosa Diagnostics amends IPO

    Ariosa Diagnostics Inc., San Jose, Calif. Business: Diagnostic Date announced: 4/29/14 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: JPMorgan; Citigroup; Leerink Partners; William Blair Note: Ariosa …

    Published on 5/5/2014
  • CardioDx amends IPO

    CardioDx Inc., Palo Alto, Calif. Business: Diagnostic Date announced: 4/28/14 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Jefferies; Piper Jaffray; William Blair Note: CardioDx filed an amended S-1 …

    Published on 5/5/2014
  • GlobeImmune amends IPO

    GlobeImmune Inc., Louisville, Colo. Business: Infectious, Cancer Date announced: 4/29/14 Type: IPO To be raised: Up to $37.2 million Shares: 2.2 million Price: $15-$17 Underwriter: Aegis Capital Overallotment: 328,125 …

    Published on 5/5/2014
  • AntriaBio financial update

    AntriaBio Inc. (OTCQB:ANTBD), Menlo Park, Calif. Business: Endocrine/Metabolic Date announced: 5/1/14 AntriaBio implemented a 1-for-6 reverse stock split and began trading under the ticker "ANTBD." Following the split, …

    Published on 5/5/2014
  • Atlas Genetics financial update

    Atlas Genetics Ltd., Trowbridge, U.K. Business: Diagnostic Date announced: 4/29/14 The company raised an undisclosed amount in the third and final tranche of a series B round, bringing the total raised to 16.9 million…

    Published on 5/5/2014
  • Bio-Techne financial update

    Bio-Techne (NASDAQ:TECH), Minneapolis, Minn. Business: Supply/Service Date announced: 4/28/14 Bio-Techne said its board declared a $0.31 per share dividend for the quarter ended March 31 to be paid on May 23 to …

    Published on 5/5/2014
  • Biotage financial update

    Biotage AB (SSE:BIOT), Uppsala, Sweden Business: Supply/Service Date announced: 4/28/14 Biotage said its board authorized the repurchase of up to 10% of the company's outstanding shares. Biotage, which closed Friday at …

    Published on 5/5/2014
  • BrainStorm financial update

    BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI), New York, N.Y. Business: Neurology Date announced: 4/25/14 BrainStorm exchanged three-year warrants issued last August to purchase up to 11.7 million shares for 5.8 …

    Published on 5/5/2014
  • Ipsen financial update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Business: Cancer, Endocrine/Metabolic, Neurology Date announced: 4/29/14 Ipsen will seek shareholder approval at a June 4 meeting to repurchase up to …

    Published on 5/5/2014
  • Knight Therapeutics financial update

    Knight Therapeutics Inc. (TSX:GUD), Westmount, Quebec Business: Infectious Date announced: 4/29/14 Knight began trading on the Toronto Stock Exchange under the symbol "GUD." Previously, the stock traded on the Toronto …

    Published on 5/5/2014
  • Lightstone Ventures L.P. financial update

    Lightstone Ventures L.P., Boston, Mass. Business: Finance Date announced: 5/1/14 Healthcare VC firm Lightstone Ventures closed its first fund with $172 million. The firm will invest about $10-$12 million each in about …

    Published on 5/5/2014
  • Questcor financial update

    Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), Anaheim, Calif. Business: Neurology, Autoimmune Date announced: 4/28/14 Questcor paid a 2Q14 dividend of $0.30 per share to shareholders. The board also declared a quarterly …

    Published on 5/5/2014
  • Sunshine Biopharma financial update

    Sunshine Biopharma Inc. (OTCQB:SBFM), Montreal, Quebec Business: Cancer Date announced: 4/29/14 Sunshine entered into a two-year share purchase agreement for up to $2.5 million with Dutchess Opportunity Fund II.

    Published on 5/5/2014
  • Topotarget financial update

    Topotarget A/S (CSE:TOPO), Copenhagen, Denmark Business: Cancer Date announced: 4/29/14 Topotarget said HealthCap decreased its stake in the company to 8.7% from 10%. Topotarget said said HealthCap's HealthCap III fund …

    Published on 5/5/2014
  • Y Combinator financial update

    Y Combinator, Mountain View, Calif. Business: Finance Date announced: 4/28/14 Startup accelerator Y Combinator said it will now fund biotechs. Y Combinator provides $120,000 in seed funding to companies in exchange for …

    Published on 5/5/2014
  • Ambrx proposes IPO

    Ambrx Inc., La Jolla, Calif. Business: Chemistry Date announced: 5/2/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Stifel, Nicolaus; Wells Fargo; Canaccord; Needham; Roth Capital …

    Published on 5/5/2014
  • BBI Diagnostics Group proposes IPO

    BBI Diagnostics Group plc, Cardiff, U.K. Business: Supply/Service Date announced: 4/29/14 Type: IPO To be raised: TBD Shares: TBD Price: TBD Note: BBI Diagnostics Group is seeking to lists its shares on the London Stock…

    Published on 5/5/2014
  • ProteinSimple proposes IPO

    ProteinSimple, Santa Clara, Calif. Business: Proteomics, Diagnostic Date announced: 5/1/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: JPMorgan; BofA Merrill Lynch; Cowen; Leerink …

    Published on 5/5/2014
  • Alder amends IPO

    Alder Biopharmaceuticals Inc., Bothell, Wash. Business: Antibodies, Autoimmune, Cancer Date announced: 4/25/14 Type: IPO To be raised: Up to $107.3 million Shares: 7.2 million Price: $13-$15 Underwriters: Credit Suisse;…

    Published on 4/28/2014
  • Aldeyra Therapeutics amends IPO

    Aldeyra Therapeutics Inc., Burlington, Mass. Business: Autoimmune, Ophthalmic Date announced: 4/25/14 Type: IPO To be raised: Up to $14.4 million Shares: 1.2 million Price: $10-$12 Underwriter: Aegis Capital …

    Published on 4/28/2014
  • Ariosa Diagnostics amends IPO

    Ariosa Diagnostics Inc., San Jose, Calif. Business: Diagnostic Date announced: 4/24/14 Type: IPO To be raised: Up to $63 million Shares: 3.5 million Price: $16-$18 Underwriters: JPMorgan; Citigroup; Leerink Partners; …

    Published on 4/28/2014
  • Radius Health amends IPO

    Radius Health Inc., Cambridge, Mass. Business: Musculoskeletal Date announced: 4/25/14 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Jefferies; Cowen; Canaccord; Cantor …

    Published on 4/28/2014
  • Arch Venture Partners financial update

    Arch Venture Partners, Chicago, Ill. Business: Finance Date announced: 4/24/14 Arch Venture Partners is looking to raise $250 million for Arch Venture Fund VIII LP, according to an SEC filing. The firm, which could not …

    Published on 4/28/2014
  • AthernoNova financial update

    AtheroNova Inc. (OTCBB: AHROD), Irvine, Calif. Business: Cardiovascular Date announced: 4/22/14 AtheroNova implemented a 1-for-10 reverse stock split and began trading under the ticker "AHROD." Following the split, …

    Published on 4/28/2014
  • BioSciKin financial update

    BioSciKin, Nanking, China Business: Finance Date announced: 4/22/14 BioSciKin, an incubator for medical products, is targeting RMB1 billion ($160.4 million) for its first fund. The fund will invest in medicines …

    Published on 4/28/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993